The topical JAK inhibitor is the first treatment approved specifically for adults with moderate-to-severe chronic hand eczema.

We chatted with dermatologists to find out what LED light therapy devices can and cannot do for your skin when it comes to ...

Despite its relatively high prevalence, eczema is a complex condition that can be triggered by a range of things, from irritants in your environment, to your mental and emotional ...

Rezpegaldesleukin (Rezpeg) shows fast, effective eczema relief in Phase 2 trial with fewer side effects than other treatments, offering hope for moderate-to-severe cases.

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a midstage study of its eczema treatment.

In this video, Jeff Yu, MD, MS, emphasized the importance of chronic hand eczema awareness and highlighted a study on the causes and treatments of the disease, presented at the Revolutionizing Atopic ...

Investors sweet on Nektar as phase 2b eczema success doubles share price By Nick Paul Taylor Jun 24, 2025 9:20am Nektar Therapeutics atopic dermatitis Clinical Data Autoimmune Diseases ...

Discover 7 dermatologist-recommended barrier-repair creams that restore damaged skin. Transform your skincare routine with these professional-grade formulas.

Nektar reported positive Phase 2b trial data for rezpegaldesleukin in atopic dermatitis, showing strong efficacy and a consistent safety profile.

Buy Now What You Should Know About the Ninja NC301 Creami Ice Cream Maker If you, like me, spend a fair amount of time on TikTok, then chances are you’ve been seeing folks using their Ninja ...